Abstract
We have directly compared the in vivo activity of a number of chemokines and phlogistins using a modified murine in vivo sponge model in which gelatin sponges are soaked with chemoattractant and implanted in the peritoneal cavity. Sponges soaked with murine JE/MCP-1 (monocyte chemoattractant protein-1) or zymosan promoted the chemotaxis of specific leukocyte populations in a time-dependent manner, as judged by multiparameter flow cytometry, with granulocytes predominating in zymosan-soaked sponges and granulocytes and macrophages present in JE/MCP-1-soaked sponges. Smaller numbers of B, T and dendritic cells were identified as well. Eotaxin selectively chemoattracted eosinophils in this model, while MIG induced significant T cell migration relative to other chemokines. Cell migration was inhibited by administration of methotrexate, piroxicam or dexamethasone, and JE/MCP-1-mediated trafficking was impaired by treatment with anti-JE antibody or with IL-10, suggesting a role for pro-inflammatory factors in amplifying the JE/MCP-1-induced response. This amplification phase involves the production of the chemokine KC, since anti-KC antibody significantly attenuated JE/MCP-1-induced chemotaxis. These results indicate that intraperitoneally implanted chemoattractant-soaked gelatin sponges are capable of inducing a pronounced inflammatory response characterized by the selective migration of leukocyte populations, and suggest that this model may be useful for delineating the activity of novel inhibitors of leukocyte chemotaxis.
Similar content being viewed by others
REFERENCES
BAGGIOLINI, M., B. DEWALD, and B. MOSER. 1997. Human chemokines: an update. Annu. Rev. Immunol., 15:675-705.
LOCATI, M., and P. M. MURPHY. 1999. Chemokines and chemokine receptors. Biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med., 50:425-440.
ZLOTNIK, A., J. MORALES, and J. A. HEDRICK. 1999. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol., 19:1-47.
SIMMONS, P. M., J. A. SALMON, and S. MONCADA. 1983. The release of leukotriene B4during experimental inflammation. Biochem. Pharmacol., 32:1353-1359.
UENO, A., K. TANAKA, and M. KATORI. 1983. Detection of leukotriene C4 and D4 in the exudate of rat carrageenin-induced pleurisy. Prostaglandins, 26:493-504.
FORD-HUCHISON, A. W., G. BRUNET, P. SAVARD, and S. CHARLESON. 1984. Leukotriene B4, polymorphonuclear leukocytes and inflammatory exudates in the rat. Prostaglandins, 28:13-27.
GRIFFITHS, R. J., S. W. LI, B. E. WOOD, and A. BLACKHAM. 1991. A comparison of the antiinflammatory activity of selective 5-lipoxygenase inhibitors with dexamethasone and colchicine in a model of zymosan induced inflammation in the rat knee joint and peritoneal cavity. Agents Actions, 2:312-320.
TADIMETI, S. R., J. L. CURRIE, A. F. SHAFFER, and P. C. ISAKSON. 1994. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther., 269:917-925.
KIKUCHI, M., K. TSUZURAHARA, and K. NAITO. 1995. Involvement of leukotriene B4 in zymosan-induced rat pleurisy: inhibition of leukocyte infiltration by the 5-lipoxygenase inhibitor T-0757. Biol. Pharm. Bull., 18:1302-1304.
PAYA, M., M. C. TERENCIO, M. L. FERRANDIZ, and M. J. ALCARAZ. 1996. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Br. J. Pharmacol., 117:1773-1779.
GARCIA-PASTOR, P., A. RANDAZZO, L. GOMEZ-PALOMA, M. J. ALCARAZ, and M. PAYA, M. 1999. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation. J. Pharmacol. Exp. Ther., 289:166-172.
ABE, M., N. HARA, T. IKEDA, N. NAGATA, and N. SHIGEMATSU. 1990. Enhanced leukotriene C4 synthase activity in thioglycollate-elicited peritoneal macrophages. Biochem. Biophys. Res. Commun., 171:1344-1352.
ABE, M., H. TAKANHASHI, T. GOUYA, N. NAGATA, and N. SHIGEMATSU. 1990. Enhanced superoxide anion generation but reduced leukotriene B4 productivity in thioglycollate-elicited peritoneal macrophages. Prostaglandins Leukot. Essent. Fatty Acids, 40:109-115.
FORD-HUTCHISON, A. W., J. R. WALKER, and J. H. SMITH. 1978. Assessment of anti-inflammatory activity by sponge implantation techniques. J. Pharmacol. Meth., 1:3-7.
HAGEN, M., I. PAEGELOW, AND P. LANGE. 1982. Assessment of chemotactic activity by means of implanted sponges. Allergie u. Immunol., 28:129-137.
GARRETT, R., B. MANTHEY, B. VERNON-ROBETS, and P. M. BROOKS. 1983. Assessment of nonsteroidal anti-inflammatory drug combinations by the polyurethane sponge implantation model in the rat. Annals Rheum. Dis., 42:439-442.
MELLOR, D. M., D. B. MYERS, and V. S. CHADWICK. 1986. The cored sponge model of in vivo leucocyte chemotaxis. Agents Actions, 18:550-554.
IUVONE, T., N. VAN OSSELAER, F. D'AQUISITO, R. CARNUCCIO, and A. G. HERMAN. 1997. Differential effect of L-NAME and S-methyl-isothiourea on leukocyte emigration in carrageeninsoaked sponge implants in the rat. Br. J. Pharmacol., 121:1637-1644.
MIDDLETON, M. M., and P. A. CAMPBELL. 1989. Functions of purified mouse neutrophils isolated from gelatin sponges. J. Leukoc. Biol., 46:461-466.
FINE, J. S., X.-Y. CAI, L. JUSTICE, C. P. GOMMOLL, L. D. HAMILTON, T. A. WATERS, S. K. NARULA, L. A. BOBER, and M. J. GRACE. 1997. A specific stimulator of granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in the mouse. Blood, 90:795-802.
HERZENBERG, L. A., A. M. STALL, P. A. LALOR, C. SIDMAN, W. A. MOORE, D. R. PARKS, and L. A. HERZENBERG. 1986. The Ly-1 B cell lineage. Immunol. Rev., 93:81-102.
HORI, Y., D.-E. HU, H. YASUI, R. L. SMITHER, G. A. GRESHAM, and T. P. D. FAN. 1996. Differential effects of angiostatic steriods and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Br. J. Pharmacol., 118:1584-1591.
MAJIMA, M., M ISONO, Y. IKEDA, L. HAYASHI, K. HATANAKA, Y. HARADA, O. KATSUMATA, S. YAMASHINA, M. KATORI, and S. YAMAMOTO. 1997. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn. J. Pharmacol., 75:105-114.
VALLERA, D. A., S. J. MENTZER, and S. E. MAIZEL. 1982. Tumor sponge implantation: an in vivo method for studying syngeneic primary antitumor lymphocyte responses. Cancer Res., 42:397-404.
AKPORIAYE, E. T., C. A. BARBIERI, C. C. STEWART, and J. G. BENDER. 1991. Gelatin sponge model of effector recruitment: tumoricial activity of adherent and non-adherent lymphokineactivated killer cells after culture in interleukin-2. J. Leukoc. Biol., 49:189-196.
FRADE, J. M., M. MELLADO, G. DEL REAL, J. C. GUTIERREZ-RAMOS, P. LIND, and C. MARTINEZ-Z. 1997. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J. Immunol., 159:5576-5584.
NAKAMURA, K., I. R. WILLIAMS, and T. S. KUPPER. 1995. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis on a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J. Invest. Dermatol., 105:635-643.
PONATH, P. D., S. X. QIN, D. J. RINGLER, I. CLARK-LEWIS, J. WANG, N. KASSAM, H. SMITH, X. J. SHI, J. A. GONZALO, W. NEWMAN, J. C. GUTIERREZ-RAMOS, and C. R. MACKAY. 1996. Cloning of the human eosinophol chemoattractant, eotaxin-expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest., 97:604-612.
LIAO, F., R. L. RABIN, J. R. YANNELLI, L. G. KONIARIS, P. VANGURI, and J. M. FARBER. 1995. Human mig chemokine: biochemical and functional characterization. J. Exp. Med., 182:1301-1314.
LOETSCHER, M., B. GERBER, P. LOETSCHER, S. A. JONES, L. PIALI, I. CLARK-LEWIS, M. BAGGIOLINI, and B. MOSER. 1996. Chemokine receptor specific for IP10 and Mig: structure, function and expression in activated T-lymphocytes. J. Exp. Med., 184:963-969.
LOETSCHER, M., P. LOETSCHER, N. BRASS, E. MEESE, and B. MOSER. 1998. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol., 28:3696-3705.
LOETSCHER, P., M. SEITZ, M. BAGGIOLINI, and B. MOSER. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med., 184:569-577.
MOSMANN, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol., 56:1-26.
KASAMA, T., R. M. STRIETER, N. W. LUKACS, M. D. BURDICK, and S. L. KUNKEL. 1994. Regulation of neutrophil-derived chemokine expression by interleukin-10. J. Immunol., 152:3559-3569.
WANG, P., P. WU, M. I. SIEGEL, R. W. EGAN, and M. M. BILLAH. 1994. Interleukin-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol., 153:811-816.
BERKAN, N., M. JOHN, G. ROESEMS, G., P. J. JOSE, P. J. BARNES, and K. F. CHUNG. 1995. Inhibition of macrophage inflammatory protein-1a expression by IL-10. Differential sensitivities of human blood monocytes and alveolar macrophages. J. Immunol., 155:4412-4418.
AJUEBOR, M. N., A. M. DAS, L. VIRAG, C. SZABO, and M. PERRETTI. 1999. Regulation of macrophage inflammatory protein-1α expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem. Biophys. Res. Commun., 255:279-282.
KIM, H. S., D. ARMSTRONG, T. A. HAMILTON, and J. M. TEBO. 1998. IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J. Leukoc. Biol., 64:33-39.
HORTON, M. R., M. D. BURDICK, R. M. STRIETER, C. BAO, and P. W. NOBLE. 1998. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J. Immunol., 160:3023-3030.
ERLICH, L. C., S. HU, P. K. PETERSON, and C. C. CHAO. 1998. IL-10 down-regulates human microglial IL-8 by inhibition of NF--κB activation. NeuroReport, 9:1723-1726.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fine, J.S., Jackson, J.V., Rojas-Triana, A. et al. Evaluation of Chemokine- and Phlogistin-mediated Leukocyte Chemotaxis Using an In Vivo Sponge Model. Inflammation 24, 331–346 (2000). https://doi.org/10.1023/A:1007044914240
Issue Date:
DOI: https://doi.org/10.1023/A:1007044914240